CPA
ERAS icon

Capital Performance Advisors’s Erasca ERAS Stock Holding History

Capital Performance Advisors’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-332
Closed -$906 – 953
2024
Q3 		$906 Buy
+332
New +$935 ﹤0.01% 1950

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Capital Performance Advisors's ERAS Position: Q4 2024 in Review

Capital Performance Advisors sold out of Erasca (ERAS) in Q4 2024, closing a stake of 332 shares — an estimated $906 sold.

Capital Performance Advisors first reported a position in ERAS in Q3 2024 and held it in 1 quarter. The position peaked at $906 in Q3 2024. 146 funds tracked by Wall St. Rank hold ERAS as of Q4 2024.

  • Capital Performance Advisors reported no remaining Erasca position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 332 Erasca shares in Q4 2024, an estimated $906.
  • Capital Performance Advisors first reported a position in Erasca in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Erasca position peaked at $906 in Q3 2024.
  • 146 funds tracked by Wall St. Rank held Erasca as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.